An Open-Label, Sequential, Dose Escalation Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

Trial Profile

An Open-Label, Sequential, Dose Escalation Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2015

At a glance

  • Drugs MDT 15 (Primary)
  • Indications Radiculopathy; Sciatica
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Medtronic
  • Most Recent Events

    • 11 Sep 2015 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016 as reported by clinicalTrials.gov.
    • 11 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by clinicalTrials.gov.
    • 10 Aug 2015 Planned End Date changed from 1 Jan 2016 to 1 Aug 2016 as reported by clinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top